埃克替尼联合抗血管药物一线治疗EGFR突变晚期肺腺癌的单中心研究
姚舒洋, 李小雪, 王淳秀, 张毅
Icotinib plus antiangiogenic agent as the first-line treatment for advanced EGFR mutant lung adenocarcinoma: a single-center study
Yao Shuyang, Li Xiaoxue, Wang Chunxiu, Zhang Yi
首都医科大学学报
.
2022, (2): 289
-293
.
DOI: 10.3969/j.issn.1006-7795.2022.02.021
